DELX (Delex Healthcare Group) EV-to-EBITDA: (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Delex Healthcare Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Delex Healthcare Group's enterprise value is $14.60 Mil. Delex Healthcare Group does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Delex Healthcare Group's EV-to-EBITDA at this moment.

The historical rank and industry rank for Delex Healthcare Group's EV-to-EBITDA or its related term are showing as below:

DELX's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.97
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-21), Delex Healthcare Group's stock price is $0.0073. Delex Healthcare Group does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Delex Healthcare Group's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Delex Healthcare Group  (OTCPK:DELX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Delex Healthcare Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0073/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Delex Healthcare Group EV-to-EBITDA Related Terms

Delex Healthcare Group EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Delex Healthcare Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delex Healthcare Group EV-to-EBITDA Chart

Delex Healthcare Group Annual Data
Trend
EV-to-EBITDA

Delex Healthcare Group Semi-Annual Data
Sep22 Sep23
EV-to-EBITDA 0.00 0.00

DELX vs PIAC, PWM, BHV: EV-to-EBITDA Comparison

For the Drug Manufacturers - General subindustry, Delex Healthcare Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delex Healthcare Group EV-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delex Healthcare Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Delex Healthcare Group's EV-to-EBITDA falls into.


Delex Healthcare Group EV-to-EBITDA Calculation

Delex Healthcare Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=14.597/
=

Delex Healthcare Group Business Description

Address Carnation Street, Blk 4, Lot 4, Cor., Magnolia, Novaliches, Quezon City, PHL, 1109
Delex Healthcare Group Inc is a healthcare-focused organization engaged in pharmaceutical and healthcare-related businesses.